Latest News in the pharma Industry
Top Stories
Japan's Santen to Acquire French Novagali
29 Sep 2011
Japanese drugmaker Santen Pharmaceutical said on Wednesday it has agreed to buy 50.55 percent of French biopharma Novagali.
Read more
Helsinn Healthcare & Riemser Arzneimittel Expand Licensing Agreement
29 Sep 2011
Helsinn Healthcare and Riemser Arzneimittel signed an agreement to grant marketing rights in Germany to Riemser for a next-generation treatment in development for the prevention of chemotherapy-induced nausea and vomiting.
Read more
AmerisourceBergen to Acquire TheraCom for $250M
28 Sep 2011
Pharmaceutical wholesaler AmerisourceBergen has agreed to buy TheraCom, a subsidiary of CVS Caremark, for $250 million.
Read more
Biotie Therapies to Acquire Newron for €45M
28 Sep 2011
Finnish biotech Biotie Therapies will purchase Italian biopharmaceutical firm Newron Pharmaceuticals for €45m.
Read more
Lonza & Mesoblast Ink Manufacturing Pact for Stem Cell Products
28 Sep 2011
Lonza has entered into a strategic alliance with Australia-based Mesoblast for the production of Mesoblast's adult stem cell therapies.
Read more
PCCA Urges Member Pharmacists to Offer Solutions for Drug Shortages
28 Sep 2011
PCCA President urges member pharmacists to continue their efforts to reduce the growing issue of drug shortages.
Read more
Merck Opens R&D Facility in Ireland
26 Sep 2011
Six drugs are currently in development at the facility, including Merck's candidate drug for the treatment of hepatitis C and a dual high cholesterol/type II diabetes medication.
Read more
SK Biopharmaceuticals with Mayo Clinic for Sclerosis Drug Development
26 Sep 2011
The South Korean biotech forms a partnership with Mayo Clinic to focus on research into chemical compounds that target a type of protein known as TDP-43.
Read more
Loxbridge with Nobel Prize Winner to Combat Superbugs
26 Sep 2011
Loxbridge Research signed a joint venture agreement to form Altermune Technologies to develop new therapeutics targeting combat resistant pathogens.
Read more
BMS & Ambrx Form Collaboration in Two Therapeutic Areas
23 Sep 2011
New York-based Bristol-Myers Squibb has inked an agreement with Ambrx to research, develop and commercialize biologics based on Ambrx's research surrounding the Fibroblast Growth Factor 21 protein and the Relaxin hormone.
Read more
India's Drug Regulators to Send Delegation to Inspect Manufacturing Sites in China
23 Sep 2011
This will be the second auditing and inspection of manufacturing facilities in China. The CDSCO delegation inspected five manufacturing sites in China in May which have been found to be in good condition.
Read more
Lilly Invests $30M in Partnership to Address Chronic Diseases
22 Sep 2011
The partnership will initially focus on diabetes - a core business area in which Lilly has deep expertise.
Read more